CHINA: Domestic Drug Makers Fined For Price Fixing

    The Chinese competition regulator has fined five domestic drug firms after finding them guilty of price-fixing. The National Development and Reform Commission (NDRC) fined include Chongqing Qingyang, Chongqing Datong, The Place Pharmaceutical (TPP), Shangqiu Huajie Pharmaceutical, and Shanghai SINE Pharmaceutical

    The full content of this article is restricted to NamNews Subscribers. If you are an existing user, please log in below. Forgotten your password? Any problems logging in, contact us

    Existing Users Log In
     Remember Me